Research article · 2021
Conference abstractPublished 12 Oct 2017
HbA1c screening for new onset diabetes following acute coronary syndrome: Is it a worthwhile test in clinical practice?
Sandwell & West Birmingham NHS Trust, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Disturbances of glucose metabolism and diabetes are widely prevalent in acute coronary syndrome (ACS) and relate to adverse outcome, irrespective of presence or absence of previously diagnosed diabetes. The aim was to use HbA1c to screen for degrees of glucose intolerance amongst non-diabetic patients admitted to our cardiology ward with ACS. Method: We developed a protocol incorporating a random HbA1c diagnostic blood test on day 2 or 3 post admission for every patient admitted with ACS without known diabetes. All HbA1c results were sent directly through to Diabetes Department via Think Glucose (TG) electronic system on iCM. As per protocol, patients were subsequently invited for a repeat HbA1c at 2 weeks, and if indeterminate result, for an oral glucose tolerance test (OGTT) at 3 months. Baseline characteristics and severity of ACS was recorded. Results: We screened 399 patients over a 1-year period (June 2014 – June 2015). The mean age was 65±14 years, 268 (67%) were male, 290 (73%) were Caucasian, 95 (24%) were South-Asian and 14 (4%) were Afro-Caribbean ethnicity. Of all patients, 57 (14.3%) were found to be pre-diabetic, 43 (10.8%) diabetic, 6 (1.5%) died and 22 (5.5%) did not attend follow-up. Of all baseline contributory factors, there were significantly more patients who were South Asian in the new diabetes group compared to the normal group (42% Vs 20%; p=0.003). However, there was no difference in new glycaemia detection rates in patients with more severe ACS, or those requiring coronary intervention or urgent cardiac surgery. Summary: This screening method has managed to accurately estimate new onset abnormal glycaemia in high-risk post ACS patients. Patients of South Asian ethnicity presenting with ACS are at highest risk of developing diabetes. All new diabetes patients receive counselling about their diagnosis and future cardiovascular risks, management plan for their GP and are enrolled into our structured diabetes education programme.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 15 Mar 2021
Some Characteristic Effects of Diabetes Mellitus on Acute Coronary Syndrome: A Narrative Review
Conference abstract · 19 Feb 2018
Coronary angiographic profile of diabetic women with acute coronary syndrome in south India
Conference abstract · 14 Sep 2015
Impact of Diabetes on hospital adverse cardiovascular outcomes in Acute Coronary Syndrome patients: Data from the Saudi project of Acute Coronary events
Research article · 2018
Diagnostic Test of Platelet Lymphocyte Ratio for Screening of Complex Coronary Lesion in Different Age Group of Acute Coronary Syndrome
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Parijat De”
